The Global Aspiration and Biopsy Needles Market is estimated to be valued at over USD 1.63 billion by 2033 and is projected to register a CAGR of over 6.7% during the forecast period of 2025 to 2033.

Fine needle aspiration focuses on a specific type of biopsy procedure. During the process of fine needle aspiration, a thin needle to inserted into the specific area of body fluid or tissue that appears abnormal. Just like with other procedures involving biopsies, a sample is drawn during the fine needle aspiration, which aids in formulating a diagnosis and rules out the possibility of any conditions such as cancer. Fine needle aspiration is typically considered a safe and secure procedure. 

The needles used during biopsy and aspiration procedures are key factors driving the significant growth of the aspiration and biopsy needles market. The market is highly competitive, with numerous prominent players.

The aspiration and biopsy needles market is likely to be propelled by the growing cancer awareness, which several government and health organizations initiate on a global scale, a high number of cancer-related occurrences, and the tendency for people to opt for surgeries that are minimally invasive. In recent years, market analysis has shown that the breast cancer segment has captured enormous attention and biopsy needles market share, owing to the prominence of development and research activities related to breast screening as well as diagnosis. Other factors also include acute awareness and knowledge about breast cancer and the rising incidence of breast cancer. However, the increased risk of infection following the insertion of aspiration and biopsy needles is expected to hamper the market potential in the future.

One of the players that has demonstrated major success in this industry is Cardinal Health, which has created innovative tools and devices, such as the ChemoPlus Chemotherapy Training Kit. It is a training and certification program that offers users a self-administered and hands-on training technique for safely managing chemotherapy drugs. They have also produced another product, known as the ChemoPlus drug transport bag, which is specifically formulated to transport chemotherapy drugs safely. Cardinal Health has further developed ChemoPlus Preparation and Administration Kits to support recommendations from ONS, ASHP, and NIOSH.

With end users, the aspiration and biopsy needles market is fragmented into academic institutes, hospitals, research laboratories, imaging and diagnostic centers. The segment for hospitals is projected to grow, in part, because of the developing healthcare framework in emerging nations. 

Global Aspiration and Biopsy Needles Market Segmentation:

By Product Type

  • Biopsy Needles
  • CNB Needles
  • VAB Needles
  • Aspiration Needles

By Procedure

  • Image-Guided Procedures
  • Non-Image-Guided Procedures

By Site

  • Breast
  • Lung
  • Colorectal
  • Prostate
  • Kidney
  • Bone and Bone Marrow
  • Other Sites

By End User

  • Hospitals
  • Research and Academic Institutes
  • Diagnostic and Imaging Centers

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East and Africa

North America holds a significant share of the global market, attributed to the presence of leading medical device manufacturers, advanced healthcare infrastructure, and high awareness levels. Europe follows closely, driven by ongoing research activities and favorable reimbursement policies. The Asia Pacific region, particularly India and China, is projected to exhibit the highest growth rate during the forecast period, fueled by increasing healthcare investments, rising cancer prevalence, and expanding diagnostic capabilities.

Major players included in the Aspiration and Biopsy Needles Market:

  • Conmed Corporation
  • Medtronic Plc
  • Olympus
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Argon Medical Devices, Inc
  • INRAD Inc.
  • Somatex Medical Technologies
  • Stryker Corporation

Recent Development

  • Olympus Corporation: In September 2022, Olympus received FDA approval for its EZ Shot Plus 25G needle, designed for enhanced flexibility and precision in endoscopic ultrasound-guided procedures.

Objectives of the Study:

  • To provide an exhaustive analysis on the Global Aspiration And Biopsy Needles Market By Product Type, By Procedure, By Site, By End User, and By Region.
  • To provide comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America, the Middle East and Africa
  • To record, evaluate, and competitive landscape mapping- product launches, technological advancements, mergers and expansions, Profiling of companies to assess their market

Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com